Maintenance ChemotherapyAntineoplastic Combined Chemotherapy Protocols6-MercaptopurinePrecursor Cell Lymphoblastic Leukemia-LymphomaCombined Modality TherapyCyclophosphamideMethotrexateThioguanineVincristineDisease-Free SurvivalChemotherapy, AdjuvantDrug Administration ScheduleRemission InductionRadiation DosageTreatment OutcomeRadiation, IonizingCytarabineEtoposideDaunorubicinRadiation InjuriesLung NeoplasmsPrednisoneLeukemia, LymphoidCarcinoma, Small CellSurvival AnalysisClinical Trials as TopicDose-Response Relationship, RadiationTime FactorsRadiation ToleranceFollow-Up StudiesRadiationRecurrenceAntineoplastic AgentsCisplatinRadiation ProtectionRadiation MonitoringDoxorubicinRadiotherapyNeoadjuvant TherapyBreast NeoplasmsNeoplasm StagingRadiation OncologySurvival RatePrognosisRadiotherapy DosageRadiation PneumonitisRadiation Injuries, ExperimentalCosmic RadiationNeoplasm Recurrence, LocalNeoplasmsCarboplatinNeoplasms, Radiation-InducedPaclitaxelInduction ChemotherapyGamma RaysRadiotherapy, AdjuvantVinblastineBackground RadiationTaxoidsBleomycinDrug Resistance, NeoplasmIfosfamideDeoxycytidineAntimetabolites, AntineoplasticRadiometryBrain NeoplasmsCarcinoma, Non-Small-Cell LungAntineoplastic Agents, AlkylatingOrganoplatinum CompoundsUltraviolet RaysAdenocarcinomaRadiation-Sensitizing AgentsSalvage TherapyRadiation EffectsNeoplasm MetastasisHodgkin DiseaseCell Line, TumorRadiation-Protective AgentsAnthracyclinesProspective StudiesDose FractionationLymphoma, Non-HodgkinOvarian NeoplasmsRadiotherapy, ConformalChemotherapy, Cancer, Regional PerfusionDacarbazineTesticular NeoplasmsTransplantation, AutologousAntineoplastic Agents, PhytogenicCarcinoma, Squamous CellDose-Response Relationship, DrugVomitingMaintenanceDNA DamageNeutropeniaKaplan-Meier EstimateHead and Neck NeoplasmsNauseaChemoradiotherapyCranial Irradiation